AWP
CELG

Ascent Wealth Partners’s Celgene Corp CELG Stock Holding History

Ascent Wealth Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,035
Closed -$525K – 129
2017
Q4 		$525K Buy
5,035
+176
+4% +$19.9K 0.2% 86
2017
Q3 		$708K Buy
4,859
+138
+3% +$18.8K 0.28% 70
2017
Q2 		$613K Sell
4,721
-94
-2% -$11.5K 0.26% 73
2017
Q1 		$599K Sell
4,815
-27
-0.6% -$3.23K 0.27% 71
2016
Q4 		$561K Buy
+4,842
New +$539K 0.28% 72

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ascent Wealth Partners's CELG Position: Q1 2018 in Review

Ascent Wealth Partners sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 5,035 shares — an estimated $525K sold.

Ascent Wealth Partners first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $708K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Ascent Wealth Partners reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Ascent Wealth Partners sold 5,035 Celgene Corp shares in Q1 2018, an estimated $525K.
  • Ascent Wealth Partners first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • Ascent Wealth Partners's Celgene Corp position peaked at $708K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Ascent Wealth Partners's 13F filing for Q1 2018, filed 21 Aug 2019.